99 related articles for article (PubMed ID: 16520039)
1. Reliable noninvasive diagnosis of coronary allograft vasculopathy: is it still wishful thinking?
Mishra PK
Eur J Cardiothorac Surg; 2006 May; 29(5):862-3; author reply 863-4. PubMed ID: 16520039
[No Abstract] [Full Text] [Related]
2. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
[TBL] [Abstract][Full Text] [Related]
3. Allograft vasculopathy: diagnosing the nemesis of heart transplantation.
Young JB
Circulation; 1999 Aug; 100(5):458-60. PubMed ID: 10430756
[No Abstract] [Full Text] [Related]
4. Risk factors for the development of coronary artery disease of a grafted heart as detected very early after orthotopic heart transplantation.
Kocík M; Málek I; Janek B; Zelízko M; Pirk J
Transpl Int; 2007 Aug; 20(8):666-74. PubMed ID: 17521382
[TBL] [Abstract][Full Text] [Related]
5. Riboflavin-mediated reduction of oxidant injury, rejection, and vasculopathy after cardiac allotransplantation.
Iwanaga K; Hasegawa T; Hultquist DE; Harada H; Yoshikawa Y; Yanamadala S; Liao H; Visovatti SH; Pinsky DJ
Transplantation; 2007 Mar; 83(6):747-53. PubMed ID: 17414708
[TBL] [Abstract][Full Text] [Related]
6. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
Soleimani B; Fu F; Lake P; Shi VC
J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883
[TBL] [Abstract][Full Text] [Related]
7. Additive effects of hyperlipidemia and rejection on development of graft coronary vasculopathy following cardiac transplantation.
El-Hamamsy I; Perrault LP
Can J Cardiol; 2005 Mar; 21(4):373; author reply 373-4. PubMed ID: 15838569
[No Abstract] [Full Text] [Related]
8. Age-dependent chronic rejection after experimental heart transplantation.
Holinski S; Modersohn D; Proch C; Meyer R; Konertz W
J Heart Lung Transplant; 2006 Sep; 25(9):1099-102. PubMed ID: 16962472
[TBL] [Abstract][Full Text] [Related]
9. Transplant vasculopathy is associated with increased AlloMap gene expression score.
Yamani MH; Taylor DO; Rodriguez ER; Cook DJ; Zhou L; Smedira N; Starling RC
J Heart Lung Transplant; 2007 Apr; 26(4):403-6. PubMed ID: 17403484
[TBL] [Abstract][Full Text] [Related]
10. Preconditioning with ozone abrogates acute rejection and prolongs cardiac allograft survival in rats.
Stadlbauer TH; Eisele A; Heidt MC; Tillmanns HH; Schulz S
Transplant Proc; 2008 May; 40(4):974-7. PubMed ID: 18555093
[TBL] [Abstract][Full Text] [Related]
11. Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients.
Kittleson MM; Bead V; Fradley M; St John ME; Champion HC; Kasper EK; Russell SD; Wittstein IS; Hare JM
J Heart Lung Transplant; 2007 May; 26(5):498-503. PubMed ID: 17449420
[TBL] [Abstract][Full Text] [Related]
12. The University of California at Los Angeles heart transplantation experience.
Kobashigawa JA; Laks H; Wu G; Patel J; Moriguchi J; Hamilton M; Fonarow G; Fishbein M; Ardehali A
Clin Transpl; 2005; ():173-85. PubMed ID: 17424734
[TBL] [Abstract][Full Text] [Related]
13. Using intramyocardial electrograms combined with other noninvasive methods for monitoring acute rejection following human heart transplantation.
Jia YX; Meng X; Sun LB; Han J; Chen YT
Chin Med J (Engl); 2009 Jan; 122(2):136-9. PubMed ID: 19187634
[TBL] [Abstract][Full Text] [Related]
14. C. sinensis ablates allograft vasculopathy when used as an adjuvant therapy with cyclosporin A.
Jordan JL; Hirsch GM; Lee TD
Transpl Immunol; 2008 Jul; 19(3-4):159-66. PubMed ID: 18619544
[TBL] [Abstract][Full Text] [Related]
15. Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.
Kirsch L; Timmermans T; Van Caenegem O; Gurne O; Noirhomme P; Jacquet LM; Latinne D; Poncelet AJ
Eur J Cardiothorac Surg; 2008 Aug; 34(2):268-74; discussion 274. PubMed ID: 18456505
[TBL] [Abstract][Full Text] [Related]
16. Cardiac surgery after heart transplantation: coronary artery bypass grafting and heart valve replacement.
Coskun KO; Coskun ST; El Arousy M; Amin Parsa M; Schulz U; Deyerling W; Tenderich G; Bairaktaris A; Koerfer R
Heart Surg Forum; 2007; 10(2):E110-4. PubMed ID: 17597032
[TBL] [Abstract][Full Text] [Related]
17. Heart retransplantation for heart allograft failure in Chinese heart transplant recipients: NTUH experience.
Chou NK; Chi NH; Chen YS; Yu HY; Lee CM; Huang SC; Hsu RB; Ko WJ; Lin FY; Chu SH; Wang SS
Transplant Proc; 2006 Sep; 38(7):2147-8. PubMed ID: 16980027
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus-associated allograft rejection in heart transplant patients.
Potena L; Valantine HA
Curr Opin Infect Dis; 2007 Aug; 20(4):425-31. PubMed ID: 17609604
[TBL] [Abstract][Full Text] [Related]
19. Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysis.
Viganò M; Tuzcu M; Benza R; Boissonnat P; Haverich A; Hill J; Laufer G; Love R; Parameshwar J; Pulpón LA; Renlund D; Abeywickrama K; Cretin N; Starling RC; Eisen HJ;
J Heart Lung Transplant; 2007 Jun; 26(6):584-92. PubMed ID: 17543781
[TBL] [Abstract][Full Text] [Related]
20. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
